Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02206581 · ClinicalTrials.gov registry record

Using Hydration Monitor to Detect Changes in the Hydration Status Athletes

A clinical trial of Dehydration, sponsored by Artann Laboratories.

Completed
Registry status
82
Enrollment target
1
Study location

NCT02206581: Completed study of Dehydration, sponsored by Artann Laboratories.

NCT02206581 is a study of Dehydration that has completed, run by Artann Laboratories. The registered enrollment target is 82 participants, above the 54-participant average among 20 other Dehydration trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02206581, a study of Dehydration, has completed, sponsored by Artann Laboratories.

COMPLETED
Registry status
82 participants
Enrollment target
1
Study location

Study Summary

The study will aim to evaluate the correlation between changes in ultrasound velocity and measures of hydration status including urine specific gravity, plasma and urine osmolality in male and female young adults after undergoing an acute dehydration and rehydration. The study will also test the hypothesis that body dehydration is a generalized physiological process equally affected all body muscles by comparing the data obtained on calf and biceps muscles.

Conditions Studied

Interventions

  • DEVICE Hydration Monitor

Study Locations (1)

North Carolina

  • Appalachian State University - Boone

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2014-10
Est. Completion 2015-12
Artann Laboratories

14 total trials

What the finished NCT02206581 record still lists

NCT02206581 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target, above the 54-participant average among 20 other Dehydration trials with a reported enrollment target (52% higher).

The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 1 intervention - of which Hydration Monitor is the first listed.

NCT02206581 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02206581 about?

NCT02206581 is a clinical study titled "Using Hydration Monitor to Detect Changes in the Hydration Status Athletes". The study will aim to evaluate the correlation between changes in ultrasound velocity and measures of hydration status including urine specific gravity, plasma and urine osmolality in male and female young adults after undergoing an acute dehydration and rehydration. The study will also test the hyp...

What is the current status of trial NCT02206581?

This trial is currently completed. The enrollment target is 82 participants. The study started on 2014-10. Estimated completion is 2015-12.

What conditions does trial NCT02206581 study?

This clinical trial studies the following conditions: Dehydration.

What interventions are being tested in trial NCT02206581?

The interventions under investigation include: Hydration Monitor (DEVICE).

Who is sponsoring clinical trial NCT02206581?

This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02206581 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02206581's enrollment target sits among peer trials

82 6th of 20 higher than 15 of 20 other Dehydration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03319901 · 82 participants · Phase 1

    Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

  • NCT03493425 · 82 participants · Phase 2

    Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

  • NCT04105270 · 82 participants · Phase 2

    RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • NCT04428658 · 82 participants · NA

    Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02206581, the US trial registry maintained by the National Library of Medicine. NCT02206581 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.